US20120097560A1 - Medication Package - Google Patents
Medication Package Download PDFInfo
- Publication number
- US20120097560A1 US20120097560A1 US13/271,580 US201113271580A US2012097560A1 US 20120097560 A1 US20120097560 A1 US 20120097560A1 US 201113271580 A US201113271580 A US 201113271580A US 2012097560 A1 US2012097560 A1 US 2012097560A1
- Authority
- US
- United States
- Prior art keywords
- medications
- package
- medication
- immunosuppressant
- blocking agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title claims abstract description 137
- 229940079593 drug Drugs 0.000 title claims abstract description 136
- 238000002483 medication Methods 0.000 claims abstract description 85
- 239000002872 contrast media Substances 0.000 claims description 16
- 229960001380 cimetidine Drugs 0.000 claims description 10
- 206010020751 Hypersensitivity Diseases 0.000 claims description 9
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical group N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims description 9
- 239000003485 histamine H2 receptor antagonist Substances 0.000 claims description 9
- 229960004618 prednisone Drugs 0.000 claims description 9
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims description 9
- 150000003431 steroids Chemical class 0.000 claims description 9
- 230000007815 allergy Effects 0.000 claims description 8
- 239000003018 immunosuppressive agent Substances 0.000 claims description 8
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims description 7
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 7
- 229960000520 diphenhydramine Drugs 0.000 claims description 7
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 7
- 230000001861 immunosuppressant effect Effects 0.000 claims description 7
- 229910052740 iodine Inorganic materials 0.000 claims description 7
- 239000011630 iodine Substances 0.000 claims description 7
- 229960004584 methylprednisolone Drugs 0.000 claims description 7
- 239000000739 antihistaminic agent Substances 0.000 claims description 6
- 239000000938 histamine H1 antagonist Substances 0.000 claims description 6
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 claims description 5
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 5
- 230000001387 anti-histamine Effects 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000009101 premedication Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000009079 Bronchial Spasm Diseases 0.000 description 2
- 208000014181 Bronchial disease Diseases 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 208000009481 Laryngeal Edema Diseases 0.000 description 2
- 206010023845 Laryngeal oedema Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 208000028185 Angioedema Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 102000000543 Histamine Receptors Human genes 0.000 description 1
- 108010002059 Histamine Receptors Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010036653 Presyncope Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000008555 Shellfish Hypersensitivity Diseases 0.000 description 1
- 102000007451 Steroid Receptors Human genes 0.000 description 1
- 108010085012 Steroid Receptors Proteins 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229960001810 meprednisone Drugs 0.000 description 1
- PIDANAQULIKBQS-RNUIGHNZSA-N meprednisone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)CC2=O PIDANAQULIKBQS-RNUIGHNZSA-N 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 201000004336 shellfish allergy Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
Definitions
- This application relates to medication packages for patients and more particularly to medication packages containing combinations of select medications to simplify the process of prescribing and administering medications.
- the present invention provides a medication package for premedicating patients with potential allergies to X-ray contrast agents.
- the package contains therein an H1 blocking agent, an H2 blocking agent, and an immunosuppressant, each contained separately in the package.
- the package includes a written protocol identifying each medication, a quantity to be taken and a time schedule for taking the medications.
- the H1 blocking agent is the antihistamine diphenhydramine (or an equivalent)
- the H2 blocking agent is cimetidine (or an equivalent)
- the immunosuppressant is prednisone (or an equivalent) or methylprednisolone (or an equivalent).
- the present invention provides a medication package enabling a single prescription to be written by the physician for administering multiple medications, the package containing a first medication, a second different medication, and a third medication different from the first and second medications.
- the package includes a written protocol specifying a dosage of each of the medications and a time interval for taking each of the three medications.
- the first, second and third medications are contained within separate compartments in the package.
- the package contains a first compartment containing each of the three medications prescribed in a first administering of the medications and a second compartment containing each of the three medications prescribed in a second administering of the medications.
- the first, second and third medications are color coded.
- the package contains medications to pre-medicate a patient with potential allergies to iodine based X-ray contrast agents.
- the first medication is an oral steroid
- the second medication is an antihistamine
- the third medication is a histamine H2 receptor antagonist.
- the present invention provides a prepackaged combination of medications enabling a physician to write a single prescription for multiple medications.
- the package comprises multiple medications grouped in a preselected (predetermined) arrangement and instructions identifying a quantity of each set of medications for the patient to take and a time interval for taking a first set of medications and a subsequent set of medications.
- the first set of medications is contained in a separate package from the subsequent set of medications.
- the instructions include a time interval for taking additional subsequent set(s) of the medications.
- each medication is contained in a separate compartment with instructions of the time to take prior to the surgical procedure.
- the prepackaged combination is designed to pre-medicate patients with potential allergies to iodine based X-ray contrast agents.
- FIG. 1 is a schematic view of a first medication package of the present invention
- FIG. 2 is a schematic view of an alternate medication package of the present invention
- FIG. 3 is a schematic view of another alternate medication package of the present invention.
- FIG. 4 is a top view of still another alternate medication package of the present invention.
- FIG. 5 is a top view of another alternate medication package of the present invention.
- each of the medication packages falls under a single prescription, with the single prescription embodying several different medications with instructions for dosage and time intervals for taking the medications.
- the convenience pack allows physicians to write one simple prescription without the necessity of remembering the doses/schedule of medications.
- the packages can have numerous applications as they can be applicable to a variety of medication combinations. Several examples of such combinations of different medications are described herein, it being understood that other medication combinations are also within the scope of the present invention.
- the medication packages are designed for use with iodinated contrast agents used in radiology and cardiology.
- the packages are designed to replace individually prescribed medications used to premedicate patients with suspected/documented allergies to X ray contrast agents, e.g. iodine based contrast agents used in radiology and cardiology.
- Iodine based X ray contrast agents are used for patients undergoing a variety of radiographic procedures including contrast enhanced computed tomography, intravenous urography, angiography, venography and myelography.
- the medications to premedicate patients include, but are not limited to, a combination of oral steroids, and histamine receptor blockers including both H1 and H2 blocking agents.
- common combinations include for example a histamine H2-receptor antagonist such as cimetidine or the equivalent, an H1 receptor antagonist such as the antihistamine diphenhydramine or the equivalent, and an immunosuppressant drug such as an oral steroid prednisone or the equivalent or methylprednisolone or the equivalent.
- a histamine H2-receptor antagonist such as cimetidine or the equivalent
- an H1 receptor antagonist such as the antihistamine diphenhydramine or the equivalent
- an immunosuppressant drug such as an oral steroid prednisone or the equivalent or methylprednisolone or the equivalent.
- the contrast agents can be administered intravenously, intra-arterially, intra-catheterally as well as into abdominal or other visceral cavities. Although, the incidence of reactions to the contrast agents is low, severe reactions can be life threatening. Reactions to contrast media administration can be divided into two basic types; anaphylactoid and non-anaphylactoid. Anaphylactoid reactions tend to mimic an anaphylactic (allergic) reaction, with enzyme induction causing the release of vasoactive substances such as histamine and serotonin and eventual activation of the complement system. These reactions can have serious and potentially fatal complications. These reactions are more frequent in patients with asthma, a history of prior reactions, a history of cardiovascular and renal disease and those on beta blockers.
- Non-anaphylactoid reactions are believed to be dependent on the physical properties of the contrast medium (tonicity and osmolality, iodine concentration and volume and rout of administration). Symptoms include warmth, metallic taste, nausea, vomiting, bradycardia, hypotension, vasovagal reactions, neuropathy and delayed reactions.
- Premedication is considered when a patient requires intravenous contrast but has had a prior reaction to the contrast. Patients with a shell-fish allergy, asthma, and/or a prior history of reactions are more prone to reactions.
- Several orally administered premedication combinations have been studied and are in current clinical practice.
- the American College of Radiology and the American College of Cardiology/Society for Cardiac angiography and interventions have also published recommendations for premedications. These include several combinations of steroids (e.g. prednisone and methylprednisoline), H1 blockers (e.g. diphenhydramine) and H2 blockers (e.g. cimetidine).
- a clemastine-cimetidine combination showed a statistically significant efficacy for prevention of angio-edema.
- a combination of steroids and H1 blockers reduced the risk of cutaneous symptoms, and a double dose of methylprednisolone reduced the risk of other symptoms like sneezing, emesis and vertigo. Consequently, the advantages of these pretreatment protocols have been well recognized.
- the packages (convenient packs) of the present invention advantageously allow dispensers to write a single prescription without the necessity of individually specifying the doses/schedule of medication. These can be based on current standard of care recommendations and modified as new treatment regimes are made practice.
- the packages also simplify the work of the dispensing pharmacist and make it easier for the patient taking the medication as the package can have color coded tablets and a printed schedule or protocol on the pack for use.
- the novel pre-packaging of medicines of the present invention eliminates the necessity of writing separate prescriptions of the individual medications as well as makes it convenient for pharmacists and patients as there will be only a single package with a single set of instructions.
- Two examples of preselected medication combinations are provided below.
- prednisone e.g. 50 mg
- diphenhydramine HCL 25 mg
- Cimetidine e.g. 300 mg
- methylprednisone e.g. 32 mg
- diphenhydramine HCL e.g. 50 mg
- Cimetidine e.g. 300 mg
- FIG. 1 illustrates one example of pre-med convenience package of the present invention containing four types of medication in Pre-Med Pack # 1 .
- the medications can be color coded and placed together in the package or provided in a separate sub-package within the package.
- three prescription medications are provided in Pre-Med Pack # 2 shown packaged together but alternately could be packaged separately.
- Pre-Med Pack # 3 of FIG. 2 has multiple medications, also packaged together or alternatively packaged separately within the convenience package.
- the dosage and time schedule for taking the medications would be included in the package. In this manner, the physician can prescribe for example one of the packages, and the pharmacy would then place the required medications in a select “pre-med package,” thereby simplifying the practice for the physician and pharmacist as well as for the patient.
- FIGS. 4 and 5 Other types of pre-med packages are shown in FIGS. 4 and 5 .
- the package of FIG. 4 corresponds to the medications of Example 1 above and the package of FIG. 5 corresponds to the medications of Example 2 above.
- each of the medications can be contained in a separate sub-package or compartment of the package, and optionally the package can contain perforations to separate the medications.
- each medicine e.g. pill
- the subpackages are separated by perforations.
- the medicines, e.g. pills are in separate sub-packages based on the time schedule and perforations separate the medications by time schedule. Stated another way, in FIG.
- the medications are in sub-packages based on the time intervals for taking the medications, e.g. the medications taken twelve hours prior to the procedure are separate from the medications taken two hours prior to the procedure.
- the medications of FIG. 5 can alternatively be packaged separately as in FIG. 4 (and the FIG. 4 medications can be packaged by time interval as in FIG. 5 ).
- Other separations and sub-packaging are also contemplated as well as other medications.
Abstract
A medication package enabling a single prescription to be written by the physician for administering multiple medications. The package contains a first medication, a second different medication, a third medication different from the first and second medications, and a written protocol specifying the dosage of each of the medications and the time schedule for taking each of the three medications.
Description
- This application claims priority from provisional application 61/405,290, filed Oct. 21, 2010, the entire contents of which are incorporated herein by reference.
- 1. Technical Field
- This application relates to medication packages for patients and more particularly to medication packages containing combinations of select medications to simplify the process of prescribing and administering medications.
- 2. Background of Related Art
- Currently, in many instances, certain combinations of prescription medications are required. In such combinations, the selection of the medications as well as the time periods for taking the medications are essential. Although there are certain established guidelines for such prescriptions, they may still vary among practitioners. Part of this variation is due to differing surgical protocols for which the medications are targeted. Problems may arise as practitioners individually prescribe these medications. Additionally, confusion and mistakes can occur by the pharmacies in creating the combinations as well as by the patients in taking the prescribed dosage at the prescribed times.
- The need exists to simplify the prescribing and administering of such combinations of select medications.
- In one aspect, the present invention provides a medication package for premedicating patients with potential allergies to X-ray contrast agents. The package contains therein an H1 blocking agent, an H2 blocking agent, and an immunosuppressant, each contained separately in the package. The package includes a written protocol identifying each medication, a quantity to be taken and a time schedule for taking the medications.
- In some embodiments, the H1 blocking agent is the antihistamine diphenhydramine (or an equivalent), the H2 blocking agent is cimetidine (or an equivalent) and/or the immunosuppressant is prednisone (or an equivalent) or methylprednisolone (or an equivalent).
- In another aspect, the present invention provides a medication package enabling a single prescription to be written by the physician for administering multiple medications, the package containing a first medication, a second different medication, and a third medication different from the first and second medications. The package includes a written protocol specifying a dosage of each of the medications and a time interval for taking each of the three medications.
- In some embodiments, the first, second and third medications are contained within separate compartments in the package. In other embodiments, the package contains a first compartment containing each of the three medications prescribed in a first administering of the medications and a second compartment containing each of the three medications prescribed in a second administering of the medications.
- In some embodiments, the first, second and third medications are color coded.
- In some embodiments, the package contains medications to pre-medicate a patient with potential allergies to iodine based X-ray contrast agents. In some embodiments, the first medication is an oral steroid, the second medication is an antihistamine and the third medication is a histamine H2 receptor antagonist.
- In another aspect, the present invention provides a prepackaged combination of medications enabling a physician to write a single prescription for multiple medications. The package comprises multiple medications grouped in a preselected (predetermined) arrangement and instructions identifying a quantity of each set of medications for the patient to take and a time interval for taking a first set of medications and a subsequent set of medications.
- In some embodiments, the first set of medications is contained in a separate package from the subsequent set of medications. In some embodiments, the instructions include a time interval for taking additional subsequent set(s) of the medications.
- In some embodiments, each medication is contained in a separate compartment with instructions of the time to take prior to the surgical procedure.
- In some embodiments the prepackaged combination is designed to pre-medicate patients with potential allergies to iodine based X-ray contrast agents.
- Preferred embodiments of the present disclosure are described herein with reference to the drawings wherein:
-
FIG. 1 is a schematic view of a first medication package of the present invention; -
FIG. 2 is a schematic view of an alternate medication package of the present invention; -
FIG. 3 is a schematic view of another alternate medication package of the present invention; -
FIG. 4 is a top view of still another alternate medication package of the present invention; and -
FIG. 5 is a top view of another alternate medication package of the present invention. - Various medication packages are disclosed herein which avoid the foregoing disadvantages of individually prescribed medications/agents which must be taken in combination by the patient. In accordance with the present invention, each of the medication packages (patient convenience packs) falls under a single prescription, with the single prescription embodying several different medications with instructions for dosage and time intervals for taking the medications. The convenience pack allows physicians to write one simple prescription without the necessity of remembering the doses/schedule of medications. The packages can have numerous applications as they can be applicable to a variety of medication combinations. Several examples of such combinations of different medications are described herein, it being understood that other medication combinations are also within the scope of the present invention.
- In one example, the medication packages are designed for use with iodinated contrast agents used in radiology and cardiology. In this example, the packages are designed to replace individually prescribed medications used to premedicate patients with suspected/documented allergies to X ray contrast agents, e.g. iodine based contrast agents used in radiology and cardiology. Iodine based X ray contrast agents are used for patients undergoing a variety of radiographic procedures including contrast enhanced computed tomography, intravenous urography, angiography, venography and myelography. The medications to premedicate patients include, but are not limited to, a combination of oral steroids, and histamine receptor blockers including both H1 and H2 blocking agents. More specifically, common combinations include for example a histamine H2-receptor antagonist such as cimetidine or the equivalent, an H1 receptor antagonist such as the antihistamine diphenhydramine or the equivalent, and an immunosuppressant drug such as an oral steroid prednisone or the equivalent or methylprednisolone or the equivalent.
- The contrast agents can be administered intravenously, intra-arterially, intra-catheterally as well as into abdominal or other visceral cavities. Although, the incidence of reactions to the contrast agents is low, severe reactions can be life threatening. Reactions to contrast media administration can be divided into two basic types; anaphylactoid and non-anaphylactoid. Anaphylactoid reactions tend to mimic an anaphylactic (allergic) reaction, with enzyme induction causing the release of vasoactive substances such as histamine and serotonin and eventual activation of the complement system. These reactions can have serious and potentially fatal complications. These reactions are more frequent in patients with asthma, a history of prior reactions, a history of cardiovascular and renal disease and those on beta blockers. These reactions typically begin within twenty minutes of injection and are dose independent. Symptoms range from mild (e.g. skin rash, itching, nasal discharge), moderate (e.g. preceding and facial/laryngeal edema, bronchospasm, dyspnea, tachycardia, bradycardia) and severe (e.g. life-threatening arrhythmias, hypotension, overt bronchospasm, laryngeal edema, pulmonary edema, seizure, syncope and death). Non-anaphylactoid reactions are believed to be dependent on the physical properties of the contrast medium (tonicity and osmolality, iodine concentration and volume and rout of administration). Symptoms include warmth, metallic taste, nausea, vomiting, bradycardia, hypotension, vasovagal reactions, neuropathy and delayed reactions.
- A full history to assess for factors predisposing a patient to contrast reaction is obtained prior to contrast administration. Premedication is considered when a patient requires intravenous contrast but has had a prior reaction to the contrast. Patients with a shell-fish allergy, asthma, and/or a prior history of reactions are more prone to reactions. Several orally administered premedication combinations have been studied and are in current clinical practice. The American College of Radiology and the American College of Cardiology/Society for Cardiac angiography and interventions have also published recommendations for premedications. These include several combinations of steroids (e.g. prednisone and methylprednisoline), H1 blockers (e.g. diphenhydramine) and H2 blockers (e.g. cimetidine). There is data that suggests that premedication with steroids prior to administration of contrast reduces contrast reactions in high risk patients. In addition, H1 and H2 blockers have been studied to further reduce the possibility of an allergic reaction. A comparison of three pretreatment protocols (oral prednisone/intramuscular diphenhydramine, plus oral cimetidine; plus oral ephedrine) favored the use of the added medications (cimetidine and ephedrine) to the pretreatment protocol for the reduction of allergic symptoms. In a review of nine trials using various premedication protocols, it was concluded that with steroid premedication, the incidence of respiratory symptoms reduced from 1.4% to 0.4%, other symptoms reduced from 0.9% to 0.2%. A clemastine-cimetidine combination showed a statistically significant efficacy for prevention of angio-edema. A combination of steroids and H1 blockers reduced the risk of cutaneous symptoms, and a double dose of methylprednisolone reduced the risk of other symptoms like sneezing, emesis and vertigo. Consequently, the advantages of these pretreatment protocols have been well recognized.
- Thus, patients with a known history of contrast reactions or of allergies to other medications or food or a history of asthma/atopy are frequently prescribed premedication with a combination of oral steroids and antihistamine agents. Although the American College of Radiology and Society for coronary angiography and intervention has guidelines regarding the choice and duration of these agents, current practice is non-standard with practitioners and institutes oftentimes choosing their own protocol. This leads to confusion regarding the drug(s) and dose prescribed.
- The packages (convenient packs) of the present invention advantageously allow dispensers to write a single prescription without the necessity of individually specifying the doses/schedule of medication. These can be based on current standard of care recommendations and modified as new treatment regimes are made practice. The packages also simplify the work of the dispensing pharmacist and make it easier for the patient taking the medication as the package can have color coded tablets and a printed schedule or protocol on the pack for use.
- Thus, as can be appreciated, the novel pre-packaging of medicines of the present invention eliminates the necessity of writing separate prescriptions of the individual medications as well as makes it convenient for pharmacists and patients as there will be only a single package with a single set of instructions. Two examples of preselected medication combinations are provided below.
- Currently, to premedicate a patient undergoing a procedure requiring injection of contrast agent for imaging, the physician would need to write: a) one prescription for prednisone (e.g. 50 mg) with instructions to take 13 hours before the procedure, seven hours before the procedure and one hour before the procedure; b) a second prescription for diphenhydramine HCL (25 mg) with instructions to take one hour before the procedure; and c) a third prescription for Cimetidine (e.g. 300 mg) with instructions to take one hour before the procedure. However, with the pre-med package of the present invention, the physician would need to write only one prescription, e.g. Pre-Med Pack A. Such Pre-Med Pack A would contain these medications with dosage and time instructions.
- Currently, to premedicate a patient undergoing a procedure requiring injection of contrast agent for imaging, the physician would need to write: a) one prescription for methylprednisone (e.g. 32 mg) with instructions to take 12 hours before the procedure and two hours before the procedure; b) a second prescription for diphenhydramine HCL (e.g. 50 mg) with instructions to take 12 hours before the procedure and two hours before the procedure; and c) a third prescription for Cimetidine (e.g. 300 mg) with instructions to take 12 hours before the procedure and two hours before the procedure. However, with the pre-med package of the present invention, the physician would need to write only one prescription, e.g. Pre-Med Pack B. Such Pre-Med Pack B would contain these medications with dosage and time instructions.
- As can be appreciated, the single prescription of the present invention simplifies the prescribing and administering of the medications.
FIG. 1 illustrates one example of pre-med convenience package of the present invention containing four types of medication inPre-Med Pack # 1. The medications can be color coded and placed together in the package or provided in a separate sub-package within the package. In the Example ofFIG. 3 , three prescription medications are provided inPre-Med Pack # 2 shown packaged together but alternately could be packaged separately.Pre-Med Pack # 3 ofFIG. 2 has multiple medications, also packaged together or alternatively packaged separately within the convenience package. The dosage and time schedule for taking the medications would be included in the package. In this manner, the physician can prescribe for example one of the packages, and the pharmacy would then place the required medications in a select “pre-med package,” thereby simplifying the practice for the physician and pharmacist as well as for the patient. - Other types of pre-med packages are shown in
FIGS. 4 and 5 . The package ofFIG. 4 corresponds to the medications of Example 1 above and the package ofFIG. 5 corresponds to the medications of Example 2 above. As shown, each of the medications can be contained in a separate sub-package or compartment of the package, and optionally the package can contain perforations to separate the medications. InFIG. 4 , each medicine, e.g. pill, is in a separate sub-package and the subpackages are separated by perforations. InFIG. 5 , the medicines, e.g. pills, are in separate sub-packages based on the time schedule and perforations separate the medications by time schedule. Stated another way, inFIG. 5 , the medications are in sub-packages based on the time intervals for taking the medications, e.g. the medications taken twelve hours prior to the procedure are separate from the medications taken two hours prior to the procedure. The medications ofFIG. 5 can alternatively be packaged separately as inFIG. 4 (and theFIG. 4 medications can be packaged by time interval as inFIG. 5 ). Other separations and sub-packaging are also contemplated as well as other medications. - While the above description contains many specifics, those specifics should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of preferred embodiments thereof. Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.
Claims (18)
1. A medication package for premedicating patients with potential allergies to X-ray contrast agents, the package comprising an H1 blocking agent, an H2 blocking agent, and an immunosuppressant medication, each contained separately in the package, and a written protocol identifying each medication, a quantity required and a time schedule for taking the medication.
2. The package of claim 1 , wherein the H1 blocking agent is the antihistamine diphenhydramine.
3. The package of claim 1 , wherein the H2 blocking agent is cimetidine.
4. The package of claim 2 , wherein the H2 blocking agent is cimetidine.
5. The package of claim 1 , wherein the immunosuppressant is one of prednisone and methylprednisolone.
6. The package of claim 2 , wherein the immunosuppressant is one of prednisone and methylprednisolone.
7. The package of claim 3 , wherein the immunosuppressant is one of prednisone and methylprednisolone.
8. The package of claim 4 , wherein the immunosuppressant is one of prednisone and methylprednisolone.
9. A medication package enabling a single prescription to be written by the physician for administering multiple medications, the package containing a first medication, a second different medication, a third medication different from the first and second medications, and a written protocol specifying the dosage of each of the three medications and the time schedule for taking each of the three medications.
10. The medication package of claim 9 , wherein the first, second and third medications are contained within separate compartments in the package.
11. The medication package of claim 9 , wherein the package contains a first compartment containing each of the three medications prescribed in a first administering of the medications and a second compartment containing each of the three medications prescribed in a second administering of the medications.
12. The medication package of claim 9 , wherein the first, second and third medications are color coded.
13. The medication package of claim 9 , wherein the package contains medications to pre-medicate a patient with potential allergies to iodine based X-ray contrast agents.
14. The medication package of claim 13 , wherein the first medication is a steroid, the second medication is an antihistamine and the third medication is a histamine H2 receptor antagonist.
15. A prepackaged combination of medications enabling a physician to write a single prescription for multiple medications, the package comprising multiple medications grouped in a predetermined arrangement and instructions identifying a quantity of a first set of medications for the patient to take, a quantity of a second set of medications for the patient to subsequently take, and the time interval between taking the first set of medications and the second set of medications.
16. The prepackaged combination of medications of claim 15 , wherein the first set of medications is contained in a separate package from the second subsequent set of medications.
17. The prepackaged combination of claim 15 , wherein each medication is contained in a separate compartment with instructions of the time to take the medications prior to a surgical procedure.
18. The prepackaged combination of claim 15 , wherein the prepackage combination is designed to premedicate patients with potential allergies to an iodine based X-ray contrast agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/271,580 US20120097560A1 (en) | 2010-10-21 | 2011-10-12 | Medication Package |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40529010P | 2010-10-21 | 2010-10-21 | |
US13/271,580 US20120097560A1 (en) | 2010-10-21 | 2011-10-12 | Medication Package |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120097560A1 true US20120097560A1 (en) | 2012-04-26 |
Family
ID=45972046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/271,580 Abandoned US20120097560A1 (en) | 2010-10-21 | 2011-10-12 | Medication Package |
Country Status (1)
Country | Link |
---|---|
US (1) | US20120097560A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130161207A1 (en) * | 2004-10-01 | 2013-06-27 | Robert A. Luciano, Jr. | Child Resistant Packaging for Multi-Prescription Order |
US8556077B1 (en) | 2012-04-19 | 2013-10-15 | Michael Hanley | Medication dispensing blister card package with adjustable mechanism that provides a custom patient schedule for complex medication regimens |
US20130299381A9 (en) * | 2004-10-01 | 2013-11-14 | Edge Medical Properties, Llc | Dual dispensing tablet container |
US20140151250A1 (en) * | 2012-11-30 | 2014-06-05 | Target Brands, Inc. | Packaged medication assembly and associated method |
US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US9428314B2 (en) | 2004-10-01 | 2016-08-30 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
US9454788B2 (en) | 2004-10-01 | 2016-09-27 | Edge Medical Properties, Llc | System and method for placing a multiple tablet order online |
US9710866B2 (en) | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
EP3402363A4 (en) * | 2016-01-13 | 2019-08-28 | Atos Medical AB | Improved carrier for maintaining personal integrity |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US20200261312A1 (en) * | 2019-02-15 | 2020-08-20 | Sailendra Upendram | Pharmaceutical container and method |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826222A (en) * | 1973-02-12 | 1974-07-30 | J Romick | Unit-dose medication handling system |
US4573580A (en) * | 1984-04-02 | 1986-03-04 | Michelle Messer | Unit dose medication dispenser |
US4972657A (en) * | 1988-01-11 | 1990-11-27 | Rna, Incorporated | Method of packaging medication for controlled dispensing |
US4976351A (en) * | 1989-06-01 | 1990-12-11 | Pharmedix | Kit for distributing pharmaceutical products |
US5261702A (en) * | 1990-08-31 | 1993-11-16 | M M & K, Inc. | Daily medication management system |
US5788974A (en) * | 1996-09-11 | 1998-08-04 | D'amico; Steven A. | Helicobacter pylori treatment compliance pack |
US6135507A (en) * | 1999-05-03 | 2000-10-24 | Moore North America, Inc. | Multi-write sample drug label system |
US20020045184A1 (en) * | 2000-10-02 | 2002-04-18 | Chih-Ming Chen | Packaging system |
US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
US20030214129A1 (en) * | 2002-05-15 | 2003-11-20 | Deborah Adler | Medication packaging and labeling system |
US6860390B2 (en) * | 2001-02-20 | 2005-03-01 | William Kenneth Bowman | Medicine organizer device |
US20060070895A1 (en) * | 2004-08-16 | 2006-04-06 | Faisal Khawaja | Drug administration kit |
USD528013S1 (en) * | 2005-11-29 | 2006-09-12 | Hines Terri D | Pill dispenser |
US20080228160A1 (en) * | 2007-03-12 | 2008-09-18 | Harrison Chad E | Essential home pharmacy kits |
US7584849B2 (en) * | 2005-07-26 | 2009-09-08 | Milford Vincent Mauk | Home medicine station |
US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
US7926850B1 (en) * | 2007-03-19 | 2011-04-19 | Muncy Lisa A | Method for managing multiple medications |
-
2011
- 2011-10-12 US US13/271,580 patent/US20120097560A1/en not_active Abandoned
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826222A (en) * | 1973-02-12 | 1974-07-30 | J Romick | Unit-dose medication handling system |
US4573580A (en) * | 1984-04-02 | 1986-03-04 | Michelle Messer | Unit dose medication dispenser |
US4972657A (en) * | 1988-01-11 | 1990-11-27 | Rna, Incorporated | Method of packaging medication for controlled dispensing |
US4976351A (en) * | 1989-06-01 | 1990-12-11 | Pharmedix | Kit for distributing pharmaceutical products |
US5261702A (en) * | 1990-08-31 | 1993-11-16 | M M & K, Inc. | Daily medication management system |
US5788974A (en) * | 1996-09-11 | 1998-08-04 | D'amico; Steven A. | Helicobacter pylori treatment compliance pack |
US6135507A (en) * | 1999-05-03 | 2000-10-24 | Moore North America, Inc. | Multi-write sample drug label system |
US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
US20020045184A1 (en) * | 2000-10-02 | 2002-04-18 | Chih-Ming Chen | Packaging system |
US6860390B2 (en) * | 2001-02-20 | 2005-03-01 | William Kenneth Bowman | Medicine organizer device |
US20030214129A1 (en) * | 2002-05-15 | 2003-11-20 | Deborah Adler | Medication packaging and labeling system |
US20060070895A1 (en) * | 2004-08-16 | 2006-04-06 | Faisal Khawaja | Drug administration kit |
US7584849B2 (en) * | 2005-07-26 | 2009-09-08 | Milford Vincent Mauk | Home medicine station |
USD528013S1 (en) * | 2005-11-29 | 2006-09-12 | Hines Terri D | Pill dispenser |
US20080228160A1 (en) * | 2007-03-12 | 2008-09-18 | Harrison Chad E | Essential home pharmacy kits |
US7926850B1 (en) * | 2007-03-19 | 2011-04-19 | Muncy Lisa A | Method for managing multiple medications |
US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
Non-Patent Citations (1)
Title |
---|
published report in Catheterization and Cardiovascular Diagnosis 1995 Feb:34(2):99-104 - Systemic Anaphylactoid Reactions to Iodinated Contrast Media During Cardiac Catheterization Procedures: Guidelines for Prevention, Diagnosis, And Treatment by Goss et al. [Goss]. * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130299381A9 (en) * | 2004-10-01 | 2013-11-14 | Edge Medical Properties, Llc | Dual dispensing tablet container |
US20130161207A1 (en) * | 2004-10-01 | 2013-06-27 | Robert A. Luciano, Jr. | Child Resistant Packaging for Multi-Prescription Order |
US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US9428314B2 (en) | 2004-10-01 | 2016-08-30 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
US9454788B2 (en) | 2004-10-01 | 2016-09-27 | Edge Medical Properties, Llc | System and method for placing a multiple tablet order online |
US9710866B2 (en) | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US8556077B1 (en) | 2012-04-19 | 2013-10-15 | Michael Hanley | Medication dispensing blister card package with adjustable mechanism that provides a custom patient schedule for complex medication regimens |
US20140151250A1 (en) * | 2012-11-30 | 2014-06-05 | Target Brands, Inc. | Packaged medication assembly and associated method |
US10176735B2 (en) * | 2012-11-30 | 2019-01-08 | Cvs Pharmacy, Inc. | Packaged medication assembly and associated method |
EP3402363A4 (en) * | 2016-01-13 | 2019-08-28 | Atos Medical AB | Improved carrier for maintaining personal integrity |
US20200261312A1 (en) * | 2019-02-15 | 2020-08-20 | Sailendra Upendram | Pharmaceutical container and method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120097560A1 (en) | Medication Package | |
Mahtani et al. | Reminder packaging for improving adherence to self‐administered long‐term medications | |
Kaufman | Pharmaceutical approval update | |
Baker et al. | Evaluation of drug information for cardiology patients. | |
Bülow et al. | Discrepancies between the medication list in electronic prescribing systems and patients' actual use of medicines | |
Schlenk et al. | Optimizing medication adherence in older patients: a systematic review | |
US20060149480A1 (en) | Method of making combination medicament and medicament made thereby | |
Peura et al. | The value of branded proton pump inhibitors: formulary considerations | |
JP2020013512A (en) | Pharmacist business support system | |
Murray et al. | Unit-dose drug distribution systems | |
Riu et al. | Implementation of a pharmaceutical care programme for patients receiving new molecular‐targeted agents in a clinical trial unit | |
Hersberger et al. | Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care | |
Kardas | An education-behavioural intervention improves adherence to statins | |
Nandagopal et al. | Assessment of rational drug prescribing pattern in geriatric patients in Hyderabad metropolitan | |
JP2004202075A (en) | Drug diagnosis system | |
Gadzhanova et al. | Fixed dose combination diabetes medicines: Usage in the Australian veteran population | |
Martinez et al. | Medication management: A case of brown bag-identified medication hoarding | |
Thomas et al. | An observational study to evaluate the factors which influence the dispensing errors in the hospital pharmacy of a tertiary care hospital | |
Coyne | The first oral fixed-dose combination of Netupitant and Palonosetron for the treatment of Chemotherapy-induced nausea and vomiting | |
JP7332854B2 (en) | Medication support system, Medication support program | |
Ferguson et al. | P63 Do paediatricians recognise childhood obesity? | |
Sipora et al. | The role of clinical pharmacist in reducing medication errors in outpatient counseling department in a secondary care hospital | |
US10702451B2 (en) | Methods and systems for grouping pharmaceutical containers according to grouping preferences | |
Lewis et al. | Prescribing for Oral Medicine in Primary Care | |
Dake et al. | A study on patient safety with reference to medication errors at a tertiary care hospital |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INTER-NOVATION CORPORATION, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CONTRACTOR, SOHAIL G.;REEL/FRAME:027163/0419 Effective date: 20111019 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |